Cigna Group/$CI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Cigna Group
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense (current contract through 2029), and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of December 2024.
Ticker
$CI
Sector
Primary listing
NYSE
Industry
Health Care Providers and Services
Headquarters
Employees
72,398
ISIN
US1255231003
Website
Cigna Group Metrics
BasicAdvanced
$79B
16.44
$17.99
0.45
$5.82
2.04%
Price and volume
Market cap
$79B
Beta
0.45
52-week high
$365.58
52-week low
$262.03
Average daily volume
1.9M
Dividend rate
$5.82
Financial strength
Current ratio
0.781
Quick ratio
0.646
Long term debt to equity
65.46
Total debt to equity
75.34
Dividend payout ratio (TTM)
31.35%
Interest coverage (TTM)
6.63%
Profitability
EBITDA (TTM)
11,471
Gross margin (TTM)
10.25%
Net profit margin (TTM)
1.97%
Operating margin (TTM)
3.83%
Effective tax rate (TTM)
21.04%
Revenue per employee (TTM)
$3,530,000
Management effectiveness
Return on assets (TTM)
4.03%
Return on equity (TTM)
13.21%
Valuation
Price to earnings (TTM)
16.438
Price to revenue (TTM)
0.32
Price to book
1.98
Price to tangible book (TTM)
-2.4
Price to free cash flow (TTM)
13.599
Free cash flow yield (TTM)
7.35%
Free cash flow per share (TTM)
2,174.43%
Dividend yield (TTM)
1.97%
Forward dividend yield
2.04%
Growth
Revenue change (TTM)
23.96%
Earnings per share change (TTM)
46.10%
3-year revenue growth (CAGR)
12.97%
10-year revenue growth (CAGR)
21.68%
3-year earnings per share growth (CAGR)
3.55%
10-year earnings per share growth (CAGR)
8.51%
3-year dividend per share growth (CAGR)
11.49%
10-year dividend per share growth (CAGR)
64.23%
What the Analysts think about Cigna Group
Analyst ratings (Buy, Hold, Sell) for Cigna Group stock.
Bulls say / Bears say
Cigna reported strong first-quarter 2025 results, with total revenues increasing 14% to $65.5 billion and adjusted income from operations reaching $1.8 billion, or $6.74 per share, surpassing analyst expectations. (advfn.com)
Barclays raised its price target for Cigna from $382.00 to $385.00, maintaining an 'Overweight' rating, indicating confidence in the company's growth prospects. (gurufocus.com)
Cigna's subsidiary, Evernorth Health Services, announced initiatives to lower out-of-pocket prescription drug costs, potentially enhancing customer satisfaction and retention. (reuters.com)
Cigna filed a lawsuit against Bristol Myers Squibb alleging antitrust violations over the cancer drug Pomalyst, which could lead to prolonged legal battles and associated costs. (reuters.com)
The company experienced a decline in Individual and Family Plans customers, contributing to a miss in fourth-quarter earnings estimates, raising concerns about membership growth. (stockinvest.us)
Wells Fargo lowered its expectations for Cigna's stock price, suggesting potential challenges in meeting future performance targets. (reporter.am)
Data summarised monthly by Lightyear AI. Last updated on 28 Jun 2025.
Cigna Group Financial Performance
Revenues and expenses
Cigna Group Earnings Performance
Company profitability
Cigna Group News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Cigna Group stock?
Cigna Group (CI) has a market cap of $79B as of July 21, 2025.
What is the P/E ratio for Cigna Group stock?
The price to earnings (P/E) ratio for Cigna Group (CI) stock is 16.44 as of July 21, 2025.
Does Cigna Group stock pay dividends?
Yes, the Cigna Group (CI) stock pays dividends to shareholders. As of July 21, 2025, the dividend rate is $5.82 and the yield is 2.04%. Cigna Group has a payout ratio of 31.35% on a trailing twelve-month basis.
When is the next Cigna Group dividend payment date?
The next Cigna Group (CI) dividend payment date is unconfirmed.
What is the beta indicator for Cigna Group?
Cigna Group (CI) has a beta rating of 0.45. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.